1、 CHEN Q, ZHANG M, LI Y,et al. CXCR7 mediates neural progenitor cells migration to CXCL12 independent of CXCR4 [J]. Stem Cells, 2015, 33(8):2574-2585. CHEN Q, ZHANG M, LI Y,et al. CXCR7 mediates neural progenitor cells migration to CXCL12 independent of CXCR4 [J]. Stem Cells, 2015, 33(8):2574-2585.
2、 SHAO Y, ZHOU F, HE D, et al. Overexpression of CXCR7 promotes mesenchymal stemcells to repair phosgene-induced acute lung injury in rats [J]. Biomed Pharmacother, 2019, 109 (1):1233-1239. SHAO Y, ZHOU F, HE D, et al. Overexpression of CXCR7 promotes mesenchymal stemcells to repair phosgene-induced acute lung injury in rats [J]. Biomed Pharmacother, 2019, 109 (1):1233-1239.
3、 KOWALSKI K, BRZOSKA E, CIEMERYCH M A. The role of CXC receptors signaling in early stages of mouse embryonic stem cell differentiation [J]. Stem Cell Res, 2019(41):101636. KOWALSKI K, BRZOSKA E, CIEMERYCH M A. The role of CXC receptors signaling in early stages of mouse embryonic stem cell differentiation [J]. Stem Cell Res, 2019(41):101636.
4、 SáNCHEZ-MARTíN L, SáNCHEZ-MATEOS P, CABA?AS C. CXCR7 impact on CXCL12 biology and disease [J]. Trends Mol Med, 2013, 19(1):12-22. SáNCHEZ-MARTíN L, SáNCHEZ-MATEOS P, CABA?AS C. CXCR7 impact on CXCL12 biology and disease [J]. Trends Mol Med, 2013, 19(1):12-22.
5、 WANG C, CHEN W, SHEN J. CXCR7 targeting and its major disease relevance [J]. Front Pharmacol, 2018(9):641. WANG C, CHEN W, SHEN J. CXCR7 targeting and its major disease relevance [J]. Front Pharmacol, 2018(9):641.
6、 TARNOWSKI M, LIU R, WYSOCZYNSKI M, et al.CXCR7: a new SDF-1-binding receptor in contrast to normal CD34(+) progenitors is functional and is expressed at higher level in human malignant hematopoietic cells [J].Eur J Haematol, 2010, 85(6):472-483. TARNOWSKI M, LIU R, WYSOCZYNSKI M, et al.CXCR7: a new SDF-1-binding receptor in contrast to normal CD34(+) progenitors is functional and is expressed at higher level in human malignant hematopoietic cells [J].Eur J Haematol, 2010, 85(6):472-483.
7、 BALABANIAN K, LAGANE B, INFANTINO S, et al. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes [J]. J Biol Chem, 2005, 280(42):35760-35766. BALABANIAN K, LAGANE B, INFANTINO S, et al. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes [J]. J Biol Chem, 2005, 280(42):35760-35766.
8、 KIM Y K, YU J H, MIN S H, et al. Generation of a GLA knock-out human-induced pluripotent stem cell line, KSBCi002-A-1, using CRISPR/Cas9 [J]. Stem Cell Res, 2020(42):101676. KIM Y K, YU J H, MIN S H, et al. Generation of a GLA knock-out human-induced pluripotent stem cell line, KSBCi002-A-1, using CRISPR/Cas9 [J]. Stem Cell Res, 2020(42):101676.
9、 GOLCHIN A, SHAMS F, KARAMI F. Advancing mesenchymal stem cell therapy with CRISPR/cas 9 for clinical trial studies [J]. Adv Exp Med Biol. 2020(1):459. GOLCHIN A, SHAMS F, KARAMI F. Advancing mesenchymal stem cell therapy with CRISPR/cas 9 for clinical trial studies [J]. Adv Exp Med Biol. 2020(1):459.
10、 WANG H, WANG M, WANG Y, et al. MSX2 suppression through inhibition of TGFβ signaling enhances hematopoietic differentiation of human embryonic stem cells [J]. Stem Cell Res Ther, 2020, 11(1):147. WANG H, WANG M, WANG Y, et al. MSX2 suppression through inhibition of TGFβ signaling enhances hematopoietic differentiation of human embryonic stem cells [J]. Stem Cell Res Ther, 2020, 11(1):147.
11、 NEGORO R, KAWAI K, ICHIKAWA M, et al. Establishment of MDR1-knockout human induced pluripotent stem cell line [J]. Drug Metab Pharmacokinet, 2020(1):9. NEGORO R, KAWAI K, ICHIKAWA M, et al. Establishment of MDR1-knockout human induced pluripotent stem cell line [J]. Drug Metab Pharmacokinet, 2020(1):9.
12、 VALENTI M T, SERENA M, CARBONARE L D, et al. CRISPR/Cas system: an emerging technology in stem cell research [J]. World J Stem Cell, 2019, 11(11):937-956. VALENTI M T, SERENA M, CARBONARE L D, et al. CRISPR/Cas system: an emerging technology in stem cell research [J]. World J Stem Cell, 2019, 11(11):937-956.
13、 TASCA F, WANG Q, GON?ALVES M. Adenoviral vectors meet gene editing: a rising partnership for the genomic engineering of human stem cells and their progeny [J]. Cells, 2020, 9(4):953. TASCA F, WANG Q, GON?ALVES M. Adenoviral vectors meet gene editing: a rising partnership for the genomic engineering of human stem cells and their progeny [J]. Cells, 2020, 9(4):953.
14、 XU L, WANG J, LIU Y, et al. CRISPR-Edited stem cells in a patient with HIV and acute lymphocytic leukemia [J]. N Engl J Med, 2019, 381(13):1240-1247. XU L, WANG J, LIU Y, et al. CRISPR-Edited stem cells in a patient with HIV and acute lymphocytic leukemia [J]. N Engl J Med, 2019, 381(13):1240-1247.
15、 MOJICA FJM, MONTOLIU L. On the origin of CRISPR-cas technology: from prokaryotes to mammals [J]. Trends Microbiol, 2016, 24(10):811-820. MOJICA FJM, MONTOLIU L. On the origin of CRISPR-cas technology: from prokaryotes to mammals [J]. Trends Microbiol, 2016, 24(10):811-820.
16、 MA Y, ZHANG L, HUANG X.Genome modification by CRISPR/Cas9 [J]. FEBS J, 2014, 281(23):5186-93. MA Y, ZHANG L, HUANG X.Genome modification by CRISPR/Cas9 [J]. FEBS J, 2014, 281(23):5186-93.
17、 ZHANG H X, ZHANG Y, YIN H. Genome editing with mRNA encoding ZFN, TALEN, and Cas9 [J]. Mol Ther, 2019, 27(4):735-746. ZHANG H X, ZHANG Y, YIN H. Genome editing with mRNA encoding ZFN, TALEN, and Cas9 [J]. Mol Ther, 2019, 27(4):735-746.
18、 NAKAZAWA T, NATSUME A, NISHIMURA F, et al. Effect of CRISPR/Cas9-mediated PD-1-disrupted primary human third-generation CAR-T cells targeting EGFRvIII on In vitro human glioblastoma cell growth[J]. Cells, 2020, 9(4):998. NAKAZAWA T, NATSUME A, NISHIMURA F, et al. Effect of CRISPR/Cas9-mediated PD-1-disrupted primary human third-generation CAR-T cells targeting EGFRvIII on In vitro human glioblastoma cell growth[J]. Cells, 2020, 9(4):998.
19、 RAN F A, HSU P D, WRIGHT J, et al. Genome engineering using the CRISPR-Cas9 system[J]. Nat Protoc, 2013, 8(11):2281. RAN F A, HSU P D, WRIGHT J, et al. Genome engineering using the CRISPR-Cas9 system[J]. Nat Protoc, 2013, 8(11):2281.
